These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1365317)

  • 41. Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes.
    Ko JS; Matharoo-Ball B; Billings SD; Thomson BJ; Tang JY; Sarin KY; Cai E; Kim J; Rock C; Kimbrell HZ; Flake DD; Warf MB; Nelson J; Davis T; Miller C; Rushton K; Hartman AR; Wenstrup RJ; Clarke LE
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1107-1113. PubMed ID: 28377414
    [No Abstract]   [Full Text] [Related]  

  • 42. Melanocytic proliferations associated with lichen sclerosus.
    Carlson JA; Mu XC; Slominski A; Weismann K; Crowson AN; Malfetano J; Prieto VG; Mihm MC
    Arch Dermatol; 2002 Jan; 138(1):77-87. PubMed ID: 11790170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Melanoma within the seborrheic keratosis.
    Thomas I; Kihiczak NI; Rothenberg J; Ahmed S; Schwartz RA
    Dermatol Surg; 2004 Apr; 30(4 Pt 1):559-61. PubMed ID: 15056152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The significance of crystalline/chrysalis structures in the diagnosis of melanocytic and nonmelanocytic lesions.
    Balagula Y; Braun RP; Rabinovitz HS; Dusza SW; Scope A; Liebman TN; Mordente I; Siamas K; Marghoob AA
    J Am Acad Dermatol; 2012 Aug; 67(2):194.e1-8. PubMed ID: 22030020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical diagnosis of dysplastic melanocytic nevi. A clinicopathologic correlation.
    Kelly JW; Crutcher WA; Sagebiel RW
    J Am Acad Dermatol; 1986 Jun; 14(6):1044-52. PubMed ID: 3722481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance of the First Step of the 2-Step Dermoscopy Algorithm.
    Chen LL; Dusza SW; Jaimes N; Marghoob AA
    JAMA Dermatol; 2015 Jul; 151(7):715-21. PubMed ID: 25714607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical diagnosis of early malignant melanomas].
    Schmoeckel C; Wagner-Grösser G; Braun-Falco O
    Hautarzt; 1985 Oct; 36(10):558-62. PubMed ID: 4066315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pediatric melanomas often mimic benign skin lesions: A retrospective study.
    Mitkov M; Chrest M; Diehl NN; Heckman MG; Tollefson M; Jambusaria-Pahlajani A
    J Am Acad Dermatol; 2016 Oct; 75(4):706-711.e4. PubMed ID: 27430613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Melanomas detected with the aid of total cutaneous photography.
    Feit NE; Dusza SW; Marghoob AA
    Br J Dermatol; 2004 Apr; 150(4):706-14. PubMed ID: 15099367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of incomplete clinical information and initial biopsy technique on the histopathological diagnosis of cutaneous melanoma.
    Kok Y; Scott K; Pham A; Liu W; Roberts H; Pan Y; McLean C; Chamberlain A; Kelly JW; Mar VJ
    Australas J Dermatol; 2021 Nov; 62(4):e524-e531. PubMed ID: 34426977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Punch 'scoring': a technique that facilitates melanoma diagnosis of clinically suspicious pigmented lesions.
    Grogan J; Cooper CL; Dodds TJ; Guitera P; Menzies SW; Scolyer RA
    Histopathology; 2018 Jan; 72(2):294-304. PubMed ID: 28796900
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-resolution laser Doppler perfusion imaging aids in differentiating between benign and malignant melanocytic skin tumours.
    Stücker M; Esser M; Hoffmann M; Memmel U; Hirschmüller A; von Bormann C; Hoffmann K; Altmeyer P
    Acta Derm Venereol; 2002; 82(1):25-9. PubMed ID: 12013193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Reliability of clinical diagnosis in malignant melanoma].
    Korom I; Gaszner G; Haraszti G; Szekeres L; Bertényi C; Dobozy A
    Orv Hetil; 1993 Jun; 134(24):1309-11. PubMed ID: 8332348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Melanocytic nevi clinically simulating melanoma.
    Makino E; Uchida T; Matsushita Y; Inaoki M; Fujimoto W
    J Dermatol; 2007 Jan; 34(1):52-5. PubMed ID: 17204102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dermoscopy as a second step in the diagnosis of doubtful pigmented skin lesions: how great is the risk of missing a melanoma?
    Carli P; De Giorgi V; Giannotti B
    J Eur Acad Dermatol Venereol; 2001 Jan; 15(1):24-6. PubMed ID: 11451316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic accuracy of malignant melanoma according to subtype.
    Lin MJ; Mar V; McLean C; Wolfe R; Kelly JW
    Australas J Dermatol; 2014 Feb; 55(1):35-42. PubMed ID: 24283461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections.
    Imam A; Mitchell MS; Modlin RL; Taylor CR; Kempf RA; Kan-Mitchell J
    J Invest Dermatol; 1986 Feb; 86(2):145-8. PubMed ID: 3528308
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.